Skip to main content
. 2022 Nov 17;13:994917. doi: 10.3389/fimmu.2022.994917

Figure 4.

Figure 4

Baseline imaging and preoperative PET/CT of two patients with NSCLC receiving neoadjuvant toripalimab with chemotherapy. (A–D) A 58-year-old male with squamous cell lung cancer (SQCC) had CMR according to iPERCIST. (A, B) show baseline axial fused image and PET, SULpeak = 14.0. (C, D) show preoperative axial fused image and PET, SULpeak = 1.44. Resection specimen showed this patient had CPR, consistent with preoperative PET. (E–H) A 65-year-olf male with adenocarcinoma had PMR according to iPERCIST. (E, F) show baseline axial fused image and PET, SULpeak = 7.86. (G, H) show preoperative axial fused image and PET, SULpeak = 2.00. Resection specimen showed this patient had CPR, inconsistent with preoperative PET. (I–L) A 52-year-olf male with adenocarcinoma had PMR according to iPERCIST. (I, J) show baseline axial fused image and PET, SULpeak = 19.0. (K, L) show preoperative axial fused image and PET, SULpeak = 10.5. Resection specimen showed this patient had IPR, consistent with preoperative PET.